Helicobacter Pylori Infection
📧 Sign up to get email alerts when something new happens for Helicobacter Pylori Infection.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2018-05-30Clinical Trial Update: Telephone-Based Re-education for Hp Eradication [NA]
The study on telephone-based re-education to improve Helicobacter pylori eradication has completed.
-
CLINICAL_TRIALS research · 2018-05-02Clinical Trial Update: Prevalence of H.Pylori in Patients With Acne Vulgaris Acne Vulgaris
The completed trial investigated the prevalence of Helicobacter pylori infection in patients with acne vulgaris.
-
CLINICAL_TRIALS trial_result · 2018-05-02Clinical Trial Update: Intraluminal Therapy for Helicobacter Pylori Infection [Phase 4]
A completed Phase 4 clinical trial conducted by Mackay Memorial Hospital evaluating intraluminal therapy for Helicobacter pylori infection.
-
CLINICAL_TRIALS trial_result · 2018-05-01Clinical Trial Update: Effectiveness of Once-daily Dose Regimen of 7-day and 14-day High Dose Rabeprazole-levofloxacin Based Quadruple Therapy for H. Pylori Eradication in Thai Patients With Non-ulcer Dyspepsia [Phase 1]
Phase 1 trial evaluating once-daily high-dose rabeprazole-levofloxacin-based quadruple therapy for eradicating Helicobacter pylori in Thai p…
-
CLINICAL_TRIALS trial_result · 2018-04-18Clinical Trial Update: Optimal Site for Rapid Urease Test in the Stomach
Completed clinical trial evaluating the optimal site for the rapid urease test in the stomach for Helicobacter pylori infection.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS research · 2018-04-10Clinical Trial Update: A Unique Regimen for Treatment of Helicobacter Pylori Infection [Phase 3]
An ongoing Phase 3 clinical trial evaluating a novel regimen for Helicobacter pylori infection, with the current status not disclosed.
-
CLINICAL_TRIALS trial_result · 2018-04-03Clinical Trial Update: Once Daily Dose Dexlansoprazole Quadruple Therapy for Helicobacter Pylori [Phase 4]
A Phase 4 clinical trial evaluating a once-daily dexlansoprazole-based quadruple therapy for Helicobacter pylori eradication has completed.
-
CLINICAL_TRIALS trial_result · 2018-03-29Clinical Trial Update: 10-day Versus 14-day Concomitant PAMC as First-line Treatment Strategy for the Eradication of H. Pylori Infection [Phase 4]
Phase 4 trial comparing a 10-day versus 14-day concomitant PAMC regimen as first-line therapy to eradicate Helicobacter pylori infection; th…
-
CLINICAL_TRIALS trial_result · 2018-02-19Clinical Trial Update: Rifaximin Associated With Classic Triple Therapy for the Eradication of Helicobacter Pylori Infection [Phase 3]
Phase 3 trial evaluating rifaximin in combination with classic triple therapy to eradicate Helicobacter pylori. Results for the study were p…
-
CLINICAL_TRIALS trial_result · 2018-02-15Clinical Trial Update: Bismuth Based Quadruple Therapy 10 Days in Children [Phase 4]
A Phase 4 clinical trial update evaluating a bismuth-based quadruple therapy over 10 days in children for Helicobacter pylori infection.
-
CLINICAL_TRIALS trial_result · 2018-01-31Clinical Trial Update: High Dose Dual Therapy (HDDT) for Eradication of Helicobacter Pylori Infection [Phase 4]
Phase 4 trial update for High Dose Dual Therapy aimed at eradicating Helicobacter pylori infection; current status is unknown.
-
FDA approval · 2018-01-25FDA Approved: BISMUTH SUBCITRATE POTASSIUM, METRONIDAZOLE AND TETRACYCLINE HYDROCHLORIDE — Supplemental Application (H2-Pharma, LLC)
FDA approved a supplemental application for a combination product containing bismuth subcitrate potassium, metronidazole, and tetracycline h…
-
FDA approval · 2018-01-24FDA Approved: NEXIUM 24HR CLEARMINIS — Supplemental Application (Haleon US Holdings LLC)
FDA approved a supplemental application for NEXIUM 24HR CLEARMINIS (esomeprazole magnesium) submitted by Haleon US Holdings LLC. The action …
-
CLINICAL_TRIALS trial_result · 2017-12-12Clinical Trial Update: Comparison of Bismuth Containing Quadruple Therapy and Based Tailored Therapy for H. Pylori Infection [NA]
This clinical trial update compares a bismuth-containing quadruple therapy to a tailored therapy approach for Helicobacter pylori infection;…
-
CLINICAL_TRIALS research · 2017-12-07Clinical Trial Update: Study the Effect of Probiotics Combined With Bismuth Quadruple Rescue Therapy on H Pylori Infective Patients
This clinical trial studies whether adding probiotics to bismuth quadruple rescue therapy improves treatment outcomes for Helicobacter pylor…
-
CLINICAL_TRIALS trial_result · 2017-12-02Clinical Trial Update: Treating H. Pylori in Parkinson's Patients With Motor Fluctuations [Phase 3]
A Phase 3 trial evaluating Helicobacter pylori eradication in Parkinson's disease patients with motor fluctuations was terminated; results w…
-
CLINICAL_TRIALS withdrawal · 2017-11-24Clinical Trial Update: An Investigation of the Association Between Helicobacter Pylori Infection and Abdominal Pain in Cystic Fibrosis Patients
A Penn State University–sponsored trial investigating the association between Helicobacter pylori infection and abdominal pain in cystic fib…
-
CLINICAL_TRIALS research · 2017-10-31Clinical Trial Update: A Relevance Study Between the Result of Clinical Drug Intervention and Next-generation Sequencing Technology Focused on Refractory Helicobacter Pylori Infection [NA]
This document reports an ongoing study examining how results of a clinical drug intervention relate to next-generation sequencing in refract…
-
FDA approval · 2017-10-30FDA Approved: GOOD NEIGHBOR PHARMACY OMEPRAZOLE — Supplemental Application (Amerisource Bergen)
The FDA approved a supplemental application for Good Neighbor Pharmacy Omeprazole (omeprazole), with AmerisourceBergen as the manufacturer, …
-
CLINICAL_TRIALS trial_result · 2017-10-30Clinical Trial Update: Performances of a Fast Test for the Detection of Helicobacter Pylori Antigens in Child Stool
A completed clinical trial evaluating a rapid stool antigen test for detecting Helicobacter pylori in children.
-
FDA approval · 2017-10-18FDA Approved: PREVACID SOLUTAB — Supplemental Application (Takeda Pharmaceuticals America, Inc.)
The FDA approved a supplemental application for Prevacid Solutab (lansoprazole) by Takeda Pharmaceuticals America, Inc., related to the Solu…
-
CLINICAL_TRIALS research · 2017-10-16Clinical Trial Update: Helicobacter Pylori Infection in Renal Transplant Patients
This update summarizes a clinical trial studying Helicobacter pylori infection in renal transplant patients. The current status of the trial…
-
FDA approval · 2017-09-28FDA Approved: OMEPRAZOLE — Supplemental Application (Sandoz Inc)
FDA approved a supplemental application for omeprazole by Sandoz Inc (ANDA 076515).
-
FDA approval · 2017-09-21FDA Approved: LANSOPRAZOLE — Original Application (Teva Pharmaceuticals USA, Inc.)
The FDA approved Teva's original ANDA for lansoprazole, enabling a generic version to be marketed for acid-related disorders.
-
CLINICAL_TRIALS trial_result · 2017-08-25Clinical Trial Update: Study of the Usefulness of the Probiotic 'Lactobacillus Reuteri' in the Therapy of Quadruple Eradication of Helicobacter Pylori Infection in Usual Clinical Practice. [Phase 4]
A Phase 4 clinical trial is evaluating the usefulness of the probiotic Lactobacillus reuteri as part of quadruple therapy for Helicobacter p…